What The Study Did: Researchers assessed the recruitment and results reporting of randomized clinical trials (RCTs) to treat or prevent COVID-19 registered within 100 days of the first case reported to the World Health Organization.
Authors: Lars G. Hemkens, M.D., M.P.H., of the University Hospital Basel in Basel, Switzerland, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https:/
(doi:10.1001/jamanetworkopen.2021.0330)
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
###
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
Media Contact
JAMA Network Media Relations
[email protected]
